Heparin-induced thrombocytopenia (HIT) is a complication of heparin therapy. HIT is characterized by a 30–50% decrease in platelet count and an increased thrombotic risk due to platelet activation. Without treatment, up to 50% of patients can experience thrombotic events.

Heparin-induced thrombocytopenia (HIT) is the development of thrombocytopenia (a low platelet count), due to the administration of various forms of heparin, an anticoagulant. HIT predisposes to thrombosis (the abnormal formation of blood clots inside a blood vessel).

2022年8月12日 · Heparin-induced thrombocytopenia (HIT) is a serious complication of taking the blood thinner heparin. With HIT, your immune system causes your platelets to clot in the presence of heparin, resulting in your platelet levels dropping. Without treatment, the clotting puts you at risk of developing life-threatening blood clots.

2025年3月5日 · Type II HIT is a much more clinically-significant, immune-mediated response to heparin that is frequently associated with the production of HIPA. Type II HIT can be associated with severe thrombosis, with the platelet count decreasing typically by 50%.

In patients with acute HIT without clinically apparent thrombosis, the ASH guideline panel suggests bilateral lower extremity compression ultrasonography to screen for asymptomatic proximal DVT .

For the treatment of tick-borne gallsickness (anaplasmosis), heartwater, footrot, navel-ill, joint-ill, pneumonia in stock and strangles in horses. For intramuscular or intravenous injection. When given by intramuscular injection, not more than 25 ml should be injected in any one site.

2023年5月16日 · Heparin-induced thrombocytopenia (HIT) is a severe complication that can occur in patients exposed to any form or amount of heparin products. A fall in platelet counts and a hypercoagulable state characterize HIT. Patients who experience HIT may also develop thromboembolic complications that are associated with significant morbidity and mortality.

Heparin-induced thrombocytopenia (HIT) is a serious complication of heparin therapy that can cause life-threatening thrombosis. HIT is caused by antibodies directed against heparin-platelet factor 4 (PF4) complexes, which can be detected by enzyme-linked and latex-enhanced immunoassays (IA) that have high diagnostic sensitivity.

HIT is a severe immune reaction to heparin therapy and is associated with high risk of venous and arterial thrombosis, making diagnosis and management critical for patient care. HIT is suspected when platelet counts decrease within 1 to 10 days after initiation of the treatment.

ELANCO HITET 120 INJECTION 100ML. Hi-Tet 120 antibiotic is used for the treatment of tick-borne gallsickness, footrot, joint ill, heartwater, navel ill and pneumonia in stock animals (cattle, sheep, goats and pigs. It is also a treatment for strangles in horses. Hi-Tet 120 is a key medicine to always have on hand.